Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TMO Thermo Fisher Scientific | ABT Abbott Laboratories |
|---|---|---|
| Price | $651.45 -1.0% | $102.61 +0.4% |
| StockIQ Score | 65B- Moderate Risk: Medium | 50C- Moderate Risk: Medium |
| Technical | 92A+ | 19F |
| Fundamental | 66B- | 72B |
| Growth | 50C- | 45D+ |
| Fair Value | 33F | 38F |
| News | 100A+ | 98A+ |
| Quality | 42D | 63C+ |
| Risk | 48D+ | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Thermo Fisher (TMO) outperforms Abbott (ABT) in technical strength with a score of 71 versus 50, making it the stronger pick in that area. However, Abbott leads in fundamentals, scoring 72 compared to TMO’s 66. Both stocks share the same valuation score of 38, and TMO has slightly higher growth and investor scores.